Home Heroes De Novo Discovery Gene Scan CDx Pathway ♻️ Repurposing 🚦 Gates Models ⚙️ MLOps 🧬 Single-Cell Quantum 🧪 Wet Lab Schedules 🎛️ Control 🧬 CIFOG 📈 Milestones 🧬 BioBrain 🧠 NPEAD Architecture 🔬 RODE 🧠 Cortex-R Workspace 🧠 V2 🧠 V3 📦 Knowledge 💰 Revenue 🧪 Tests 📊 Costs 📚 Datasets

🧬 CDx / Diagnostic / Prognostic Biomarker Panel

Updated Pipeline: Candidates validated through De Novo → Uni-Dock GPU docking → GNINA rescore → MD gate (OpenMM 5ns GAFF2, RMSD < 3Å, residence > 80%) → Heroes.

✅ Promote Advance to CDx dev 🔬 Validate Run Uni-Dock + MD ♻️ Repurpose Check existing drugs ⚛️ VQE Quantum validation 🧪 WetLab Order assay kit 📄 Report Generate CDx dossier

CDx Categories: 🔬 Dx = Diagnostic (detect cancer) 📈 Px = Prognostic (predict outcome) 🎯 Dx+Px = Both 💊 Tx = Therapeutic companion 🧬 Monitor = Treatment response monitoring

Prostate cancer companion diagnostics — gene expression predicts therapy response or patient outcome.
Dx = Diagnostic (detect cancer) · Px = Prognostic (predict outcome) · Dx+Px = Both

⏳ Awaiting GPU Docking

#	Gene	Cancer	Target Class	Druggability	Specialist	Status	Actions

Biomarker Panel

#	Gene	Type	Grade	Trust	Vina	MD	Drug Pipeline	Pathway	CDx Use	Novel?	TCGA	Actions

Clinical Application Summary

💊 Diagnostic & Prognostic Kits + Platform Products

Commercial product portfolio — governed biomarker kits and platform services.

#	Product	Category	Genes	Drug Decision	Description

#TitleTypeGenesLink